Siga Technologies Inc is a biotechnology company focused on developing solutions for public health threats, particularly through its innovative antiviral therapeutics

The company's primary emphasis is on the advancement of treatments for viral infections, with a notable concentration on smallpox and other serious infectious diseases. By leveraging its proprietary technologies, Siga aims to address unmet medical needs and improve health outcomes, especially in the face of potential bioterrorism threats or emerging viral outbreaks. Through collaborations with government entities and investment in research, the company endeavors to enhance global health security and preparedness through effective medical interventions.